[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 1, 1998

Risks and Benefits of Varicella Vaccine

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(13):993-994. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-13-jbk0401

To the Editor.—The Editorial by Drs Shapiro and LaRussa1 argues for universal varicella immunization without a clear understanding of the concerns of those against that strategy. We agree with several points.

Varicella causes morbidity and mortality especially among adults. Universal immunization is difficult to achieve, and adults rarely comply with immunization recommendations. Immunization programs targeted at children, especially those coupled with school-required physical examinations, have greater compliance rates. The duration of immunity from varicella virus vaccine in a world without natural boosting from exposure to wild disease is unknown (despite the suggestion from 1 study2 that it may be long-lasting). Less than universal childhood immunization for varicella may increase adult morbidity and mortality.

First Page Preview View Large
First page PDF preview
First page PDF preview
×